Four more Hoosiers sue Juul for deceptive advertising in e-cigarettes
The latest lawsuit says the company targeted young people for its flavored e-cigarettes without warning that the products were highly addictive and dangerous.
The latest lawsuit says the company targeted young people for its flavored e-cigarettes without warning that the products were highly addictive and dangerous.
Matthew Sause, 42, returns to Roche Diagnostics Corp., where he worked for 17 years before leaving briefly this year for a senior position at Gilead Sciences.
Key parties in the case have asked state regulators to order Duke to refile all its work papers and exhibits, with formulas and linked spreadsheets.
The federal government says readmissions are often unnecessary and cost taxpayers tens of billions of dollars a year for treatments that should have been caught the first time around, or were not followed up adequately.
The drug, called pegilodecakin, had been seen as a promising treatment for one of the deadliest types of cancer, and was the lead product in Lilly’s $1.6 billion acquisition of Armo BioSciences last year.
The Virginia-based firm said Tuesday it has invested $18 million to set up a 70,000-square-foot biologics logistics center near the Indianapolis International Airport. It is currently hiring managers and technicians.
One in six Hoosier children aged 10 to 17 is obese, making Indiana among the worst states in the nation for childhood obesity, according to a new study from the Robert Wood Johnson Foundation.
Every day, thousands of Americans get a surprise bill in the mail from a health provider, asking for thousands of dollars for medical services that weren’t covered by the patient’s insurance.
Indiana health officials are investigating 30 cases of severe lung injury linked to vaping. Eight of those have been confirmed—most of them among individuals between the ages of 16 and 29. Earlier this month, the state confirmed the first death linked to vaping.
The plaintiffs say the requirements jeopardize the health coverage of thousands of vulnerable people under the Healthy Indiana Plan.
The spinoff, called Sexton Biotechnologies, has raised $5 million in outside investment and will spin off in October. The biotech develops cell and gene therapy tools used to grow cells for medical purposes.
One of Indiana’s oldest and largest senior communities has broken ground on its fifth addition in seven years. Owner BHI Senior Living says it has a “robust waiting list” at Hoosier Village.
Since the first pager was patented in 1949 and used in New York’s Jewish Hospital, millions of doctors have done their daily rounds in hospitals with the gadget clipped to their waistband, always ready to hear the beep that might signal a medical crisis on the other end. But hospitals are now phasing them out.
In July, Dr. Carol Anne Murdoch-Kinch became the first female dean of the Indiana University School of Dentistry in its 140-year history.
Nearly half of Americans with private insurance—47%—are covered by high-deductible plans, up from 25% in 2010. That’s driven up out-of-pocket health spending among people with employer coverage—from $493 in 2007 to $792 in 2017.
Paul Elmer, 68, of Fishers, was sentenced Wednesday in U.S. District Court in Indianapolis, six months after a jury found him guilty of nine counts of adulterating compounded drugs and one count of conspiracy.
Professor Alex Erkine is combining biochemistry with machine learning to try to solve an age-old riddle of how to identify and regulate problem genes.
The new venture, called MBX Biosciences Inc., aims to develop therapeutics to treat rare endocrine disorders. The company has already raised $2.5 million in funding.
Capitol Village Healthcare, a 52-bed nursing home at 2926 N. Capitol Ave., closed earlier this year, and had received low ratings from U.S. News and the Centers for Medicare & Medicaid Services.
Last year, Taltz rang up sales of $937.5 million, and doctors are increasingly prescribing it. For the first six months of this year, Taltz recorded $606.3 million in sales, putting it on pace to break the $1 billion threshold, perhaps in the third quarter.